| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.097 | 0.07 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.068 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.066 | 0.3 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.035 | 0.5 |